IP Library Granted Patent US 12,529,079
Granted Patent B2
US 12,529,079 · App. 17/105,100 · Granted Jan 20, 2026

Process for displacing an exogenous enzyme

Inventors: Aaron Argyros (Lebanon, NH); Alexandra Panaitiu (Enfield, NH); Charles Rice (Plainfield, NH); Matthew B. Richards (Lebanon, NH); Tera Stoughtenger (New Lisbon, WI); Kenneth Barrett (San Diego, CA)
Assignee: Danstar Ferment AG
C12P7/06C12N1/18C12N9/60
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,529,079
App. No.
17/105,100
Granted
Jan 20, 2026
Kind
B2
Abstract

The present disclosure concerns a process for fermenting a biomass with a reduced dose of a purified exogenous enzyme (which can be, for example a purified exogenous glucoamylase). The process comprises contacting a biomass (which may comprise starch) with a recombinant yeast host cell. The recombinant yeast host cell has a genetic modification for expressing a heterologous polypeptide having starch or dextrin hydrolase activity (which may be, for example, from a glucoamylase). The nucleic acid molecule encoding the heterologous polypeptide having starch or dextrin hydrolase activity comprises allowing the secretion of the heterologous polypeptide.

Claims (34)

1 . A process for fermenting a biomass into ethanol comprising:

(i) propagating a stabilized liquid yeast dose of between 30 and 210 kg of a recombinant yeast host cell to obtain propagated recombinant yeast host cells;

(ii) contacting the propagated recombinant yeast host cells with a biomass in a fermentor having a working volume of at least 100,000 gallons, under a condition that allows conversion of at least a part of the biomass into ethanol, wherein:

the biomass comprises starch or a starch derivative;

the propagated recombinant yeast host cells express a heterologous nucleic acid molecule encoding a heterologous glucoamylase, wherein the heterologous nucleic acid molecule comprises a first polynucleotide encoding a heterologous signal sequence of SEQ ID NO: 5; and a second polynucleotide encoding the heterologous glucoamylase, wherein the heterologous glucoamylase is a secreted glucoamylase; and

the first polynucleotide molecule is operatively associated with the second polynucleotide molecule;

(iii) adding an exogenous glucoamylase to the biomass of the fermentor, wherein the added exogenous glucoamylase is displaced by at least 80% by weight when compared to a control fermentation;

(iv) fermenting the biomass with the propagated recombinant yeast host cells in the presence of the exogenous glucoamylase to achieve an ethanol yield of at least 0.440% w/v of ethanol per w/w of biomass; and

(v) recovering ethanol,

wherein the recombinant yeast host cell is from the genus Saccharomyces.

2 . The process of claim 1 , wherein the polypeptide having glucoamylase activity has the amino acid sequence of SEQ ID NO: 3 or 13, is a variant having at least 90% identity with the amino acid sequence of SEQ ID NO: 3 or 13 and having glucoamylase activity, or is a fragment having at least 90% identity with the amino acid sequence of SEQ ID NO: 3 or 13 and having glucoamylase activity.

3 . The process of claim 1 , wherein the heterologous nucleic acid molecule further comprises a third polynucleotide comprising a heterologous promoter operatively associated with the first polynucleotide and the second polynucleotide allowing the expression of the heterologous glucoamylase.

4 . The process of claim 3 , wherein the heterologous promoter is capable of allowing the expression of the heterologous glucoamylase during propagation.

5 . The process of claim 1 , wherein the recombinant yeast host cell comprises a further heterologous nucleic acid molecule encoding a heterologous alpha-amylase and/or a further heterologous glucoamylase.

6 . The process of claim 5 , wherein the heterologous alpha-amylase has the amino acid sequence of any one of SEQ ID NO: 17 to 26, is a variant having at least 90% identity with the amino acid sequence of any one of SEQ ID NO: 17 to 26 and having alpha-amylase activity or is a fragment having at least 90% identity with the amino acid sequence of any one of SEQ ID NO: 17 to 26 and having alpha-amylase activity.

7 . The process of claim 5 , wherein the further heterologous glucoamylase has the amino acid sequence of any one of SEQ ID NO: 27 to 36, a variant having at least 90% identity with the amino acid sequence of any one of SEQ ID NO: 27 to 36 and having glucoamylase activity or a fragment having at least 90% identity with the amino acid sequence of any one of SEQ ID NO: 27 to 36 and having glucoamylase activity.

8 . The process of claim 1 , wherein the recombinant yeast host cell is from the species Saccharomyces cerevisiae.

9 . The process of claim 1 , wherein the biomass is derived from or comprises corn, potato, cassava, rice, wheat, lignocellulosic material, milo or buckwheat.

10 . The process of claim 9 , wherein the biomass is derived from or comprises corn.

11 . The process of claim 10 , wherein the biomass comprises or is corn mash.

12 . The process of claim 1 , wherein the added exogenous glucoamylase is displaced by at least 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 100% by weight.

13 . The process of claim 1 , wherein the added exogenous glucoamylase is displaced by 100% by weight.

14 . The process of claim 1 , wherein the stabilized liquid yeast dose is between 112.4 kg and 168.5 kg.

15 . The process of claim 1 , wherein the added exogenous glucoamylase is displaced by at least 90% by weight.

16 . The process of claim 1 , wherein the added exogenous glucoamylase is displaced by at least 85% by weight.

17 . The process of claim 1 , wherein the control fermentation (i) is conducted with a control yeast host cell that does not express the heterologous glucoamylase and (ii) achieves an ethanol yield of at least 0.440% w/v of ethanol per w/w of biomass.

18 . A process for fermenting a biomass into ethanol comprising:

(i) providing a stabilized liquid yeast dose of between 30 and 210 kg of a recombinant yeast host cell, wherein the recombinant yeast host cell expresses a heterologous nucleic acid molecule encoding a heterologous glucoamylase, wherein the heterologous nucleic acid molecule comprises a first polynucleotide encoding a heterologous signal sequence of SEQ ID NO: 5 and a second polynucleotide encoding the heterologous glucoamylase wherein the heterologous glucoamylase is a secreted glucoamylase, and wherein the first polynucleotide molecule is operatively associated with the second polynucleotide molecule;

(ii) propagating the stabilized liquid yeast dose to obtain a quantity of propagated recombinant yeast host cells;

(iii) contacting the quantity of propagated recombinant yeast host cells with a biomass in a fermentor having a working volume of at least 100,000 gallons, wherein step (iii) results in the conversion of a portion of the biomass into ethanol, and wherein step (iii) achieves the displacement of 100% by weight of an exogenous glucoamylase when compared to a control fermentation;

(iv) fermenting the biomass with the propagated recombinant yeast host cells to achieve an ethanol yield of at least 0.440% w/v of ethanol per w/w of biomass; and

(v) recovering ethanol,

wherein the recombinant yeast host cell is from the genus Saccharomyces.

19 . The process of claim 18 , wherein the control fermentation (i) is conducted with a control yeast host cell that does not express the heterologous glucoamylase and (ii) achieves an ethanol yield of at least 0.440% w/v of ethanol per w/w of biomass.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 9, 2024
From: BASF SE
To: DANSTAR FERMENT AG
Reel/Frame 068847/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2024
From: LALLEMAND HUNGARY LIQUIDITY MANAGEMENT LLC
To: DANSTAR FERMENT AG
Reel/Frame 068174/0430 →
CORRECTIVE ASSIGNMENT TO CORRECT THE OMMISION OF INVENTOR #4 AND INVENTOR #5 PREVIOUSLY RECORDED ON REEL 056333 FRAME 0868. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jul 19, 2021
From: ARGYROS, AARON; PANAITIU, ALEXANDRA; RICE, CHARLES; RICHARDS, MATTHEW B.; STOUGHTENGER, TERA
To: LALLEMAND HUNGARY LIQUIDITY MANAGEMENT LLC
Reel/Frame 056909/0501 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 24, 2021
From: ARGYROS, AARON; PANAITIU, ALEXANDRA; RICE, CHARLES
To: LALLEMAND HUNGARY LIQUIDITY MANAGEMENT LLC
Reel/Frame 056333/0868 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 24, 2021
From: BARRETT, KENNETH
To: BASF ENZYMES LLC.
Reel/Frame 056333/0887 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 24, 2021
From: BASF ENZYMES LLC.
To: BASF SE
Reel/Frame 056333/0895 →
Continuity (4)
Provisional Application 63078139 · Sep 14, 2020
Provisional Application 63078135 · Sep 14, 2020
Provisional Application 62941967 · Nov 29, 2019
Related Publication 20210163995A1 · Jun 3, 2021
References Cited (69)
US 4021579A · Barrett · 1977 [cited by examiner]
US 6255084B1 · Nielsen et al. · 2001 [cited by applicant]
US 6620924B2 · Nielsen et al. · 2003 [cited by applicant]
US 7060468B2 · Nielsen et al. · 2006 [cited by applicant]
US 7129069B2 · Borchert et al. · 2006 [cited by applicant]
US 7312055B2 · Borchert et al. · 2007 [cited by applicant]
US 7749744B2 · Borchert et al. · 2010 [cited by applicant]
US 8216817B2 · Gill et al. · 2012 [cited by applicant]
US 8557541B2 · Landvik · 2013 [cited by examiner]
US 8956851B2 · Argyros et al. · 2015 [cited by applicant]
US 9206444B2 · Brevnova et al. · 2015 [cited by applicant]
US 9605269B2 · Sillers et al. · 2017 [cited by applicant]
US 9650620B2 · Sun et al. · 2017 [cited by applicant]
US 9719098B2 · Argyros et al. · 2017 [cited by applicant]
US 10253337B2 · Cripwell et al. · 2019 [cited by applicant]
US 10294484B2 · Brevnova et al. · 2019 [cited by applicant]
US 10344288B2 · Miller · 2019 [cited by examiner]
US 10364421B2 · Miller · 2019 [cited by examiner]
US 10385345B2 · Brevnova et al. · 2019 [cited by applicant]
US 10570421B2 · Rice et al. · 2020 [cited by applicant]
US 20030027290A1 · Nielsen · 2003 [cited by examiner]
US 20070092602A1 · Degre · 2007 [cited by examiner]
US 20090017164A1 · Schisler · 2009 [cited by examiner]
US 20090117633A1 · Bradley · 2009 [cited by examiner]
US 20100021967A1 · Draborg · 2010 [cited by examiner]
US 20130217072A1 · Den Haan · 2013 [cited by examiner]
US 20130323822A1 · Brevnova · 2013 [cited by examiner]
US 20160108448A1 · Ge · 2016 [cited by examiner]
US 20160194669A1 · Argyros et al. · 2016 [cited by applicant]
US 20160264927A1 · Miasnikov · 2016 [cited by examiner]
US 20170321237A1 · Fukuyama · 2017 [cited by examiner]
US 20170356000A1 · Argyros et al. · 2017 [cited by applicant]
US 20180155744A1 · Cripwell · 2018 [cited by examiner]
US 20180265853A1 · Rice et al. · 2018 [cited by applicant]
US 20180355387A1 · Javers · 2018 [cited by examiner]
US 20190345471A1 · Miller et al. · 2019 [cited by applicant]
US 20200063221A1 · Jauert et al. · 2020 [cited by applicant]
US 20200095592A1 · Brevnova et al. · 2020 [cited by applicant]
US 20200157581A1 · Hogsett · 2020 [cited by examiner]
US 20200231991A1 · Rice et al. · 2020 [cited by applicant]
US 20210040523A1 · Ge · 2021 [cited by examiner]
CA 2517920A1 · 2004 [cited by applicant]
CA 2629821A1 · 2007 [cited by applicant]
CA 2730243A1 · 2010 [cited by applicant]
WO WO2013013126 · 2013 [cited by examiner]
WO 2017037614A1 · 2017 [cited by applicant]
WO 2018002360A1 · 2018 [cited by applicant]
WO 2018027131A1 · 2018 [cited by applicant]
WO 2018167670A1 · 2018 [cited by applicant]
WO 2019191263A1 · 2018 [cited by applicant]
WO 2019168962A1 · 2019 [cited by applicant]
WO 2019175809A1 · 2019 [cited by applicant]
WO 2020100069A1 · 2020 [cited by applicant]
He et al., Cloning of a novel thermostable glucoamylase from thermophilic fungus [cited by examiner]
SEQIDNO-17-align , Sequence Alignment file for SEQ ID No. 17 (Year: 2021). [cited by examiner]
SEQIDNO-3-align , Sequence Alignment file for SEQ ID No. 3 (Year: 2021). [cited by examiner]
SEQIDNO-5-align , Sequence Alignment file for SEQ ID No. 5 (Year: 2021). [cited by examiner]
SEQIDNO-27-align , Sequence Alignment file for SEQ ID No. 27 (Year: 2021). [cited by examiner]
Liquiferm (Liquiferm®, Lallemand Biofuels and Distilled Spirits, Webpage, Nov. 26, 2018 (Year: 2018). [cited by examiner]
Görgens, Johann F., David C. Bressler, and Eugéne van Rensburg. “Engineering [cited by examiner]
Jansen, “Same Corn, More Value: Industrially Proven Yeast Technology,” [cited by applicant]
Nielsen, “Production of biopharmaceutical proteins by yeast: Advances through metabolic engineering,” [cited by applicant]
Richards, “TransFerm® & TransFerm®: Yield +: Maximizing Profitability within Ethanol Facilities,” [cited by applicant]
Richards, “Measurement of Ethanol Yield in Grain Ethanol Plant Trials,” [cited by applicant]
Richards, “Pushing the Limits on Yield: Advanced Yeasts Providing Further Efficiencies in Fuel Ethanol Production,” [cited by applicant]
Richards, “Biotech Yeast: A Decade of Innovation to Assist Producers,” 34th International Fuel Ethanol Workshop & Expo, Jun. 13, 2018, 27 pages. [cited by applicant]
Richards, “Advanced Yeasts: Continuing Innovation in Response to Producer Requirements,” [cited by applicant]
Richards, “The Next Generation of Yeast-Expressed Enzymes to Enhance Production,” [cited by applicant]
Cripwell al., “Construction of industrial [cited by applicant]